PHOTO CREDIT: Mayo Clinic

Biomedical Research News

  • Could regenerative medicine relieve neck, back pain?

    Mayo Clinic is looking to regenerative medicine as a potential long-term solution for degenerative disk disease that has for years eluded medical science. Millions of people in the U.S. are afflicted with chronic neck and back pain that often comes after years of wear and tear on the spine. Current treatments provide only temporary relief for this common disorder, and finding a cure has been a great challenge for researchers. Wenchun Qu, M.D., Ph.D., a physiatrist and pain specialist at Mayo Clinic in Florida, and director of Regenerative Pain Medicine at the Center for Regenerative Medicine, hypothesizes that therapeutic answers to degenerative disk disease are hidden in mesenchymal stem cells. Dr. Qu's hypothesis is that mesenchymal stem cells could provide a new option for reducing inflammation, relieving pain and restoring spinal disks. He is applying his research to a regenerative medicine service he began at Mayo Clinic in Rochester and has now introduced at Mayo Clinic in Florida. In addition to this work, Dr. Qu is leading other regenerative medicine research to investigate the safety, feasibility and effectiveness of using bone marrow-derived mesenchymal stem cells to treat spine osteoarthritis with support from Gerstner Philanthropies.

    Read more at mayoclinic.org
  • MSK Recognizes 2021 Gerstner Sloan Kettering (GSK) Graduates During Virtual Commencement

    During a virtual commencement ceremony on Wednesday, May 19, 2021, at 3:00 pm et, Memorial Sloan Kettering Cancer Center (MSK) recognized seven Gerstner Sloan Kettering (GSK) 2021 graduates and honor Joan Argetsinger Steitz, PhD, Sterling Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine and a Howard Hughes Medical Institute Investigator, with the 2021 Honorary Degree and the Memorial Sloan Kettering Medal for Outstanding Contributions to Biomedical Research. Established in 2004 with a landmark gift from Louis V. Gerstner, Jr., member of the MSK Boards of Trustees and Governing Trustees and chairman of the board of GSK, GSK admitted its first class in the summer of 2006. The school offers the next generation of biomedical scientists an intensive PhD program that trains them to investigate and attack cancer through the twin lenses of basic research and real-life clinical challenges.

    Read more at newswise.com
  • Louis V. Gerstner, Jr. to Conclude 8 Year Term as Chair of Broad Institute Board

    The Broad Institute of MIT and Harvard announced today that renowned technologist, entrepreneur and philanthropist Eric Schmidt will become the next Chair of the Board of Directors, succeeding Louis V. Gerstner, Jr., who has served as Chair of the Board since 2013. Under his leadership as Chair, the Broad Institute has expanded its focus and impact around mental illness, genome editing, cancer diagnostics, therapeutics and drug discovery, developing software tools to drive the intersection of biology and machine learning, COVID-19 testing and research to serve public health needs, and more.

    Read more at broadinstitute.org
  • Columbia University Announces 2021 Louis V. Gerstner Jr., Scholars

    Four physician-scientists at the Vagelos College of Physicians and Surgeons—Jennifer Gelinas, Catherine Spina, Aaron Viny, and Xiao Zhao—have been named 2021 Louis V. Gerstner Jr. Scholars. Eliza C. Miller, a 2018 Gerstner Scholar, has been named a 2021 Louis V. Gerstner Jr. Merit Awardee. Since 2008, The Louis V. Gerstner Jr. Scholars Program has supported tenure-track physicians who conduct research that has the promise to bring new treatments to patients. The fund provides a stipend of $75,000 per year, for up to three years, to support the awardees’ research projects. Scholars are nominated by a committee of distinguished research faculty and selected by the VP&S dean. The program also presents the Gerstner Merit Award to an outstanding third-year Louis V. Gerstner Jr. Scholar who has made great strides in research.

    Read more about this year's scholars at columbia.edu